Find Academic Supervisors

R. Michael BurgerView profile

Professor

• Auditory Neuroscience
• Neural Circuitry
• Synaptic Physiology
• +3 more

R. Michael Burger is a Professor in the Department of Biological Sciences at Lehigh University and serves as the Associate Dean for Research and Graduate Programs in the College of Arts and Sciences. His research focuses on auditory neuroscience, particularly how the brain processes sensory information through precise neural circuits. Education Ph.D. in Zoology (Neurobiology) from the University of Texas at Austin (2000) B.A. in Psychology and Anthropology from Ithaca College (1993) Dr. Burger's research investigates cellular, synaptic, and systems-level integration in auditory processing, with NIH-funded projects on sound localization and cholinergic modulation. He has edited books on neuromodulatory functions and serves on editorial boards of leading journals. Recent publications highlight his work on dopamine and cholinergic influences in auditory pathways, developmental synaptic plasticity, and computational auditory neuroscience. Grants include NIH R01 and R15 awards. Scientific Awards Fellow, Alexander von Humboldt Foundation Dr. Burger teaches behavioral neuroscience courses and contributes to graduate committee work, otolaryngology research, and grant review panels. He co-developed the HearMyCl app for cochlear implant simulations with Susan Perry and Brook Sawyer.

Russell CarrView profile

Professor

• Toxicology
• Neurotoxicology
• Environmental Health
• +3 more

Russell Carr , PhD, is a Professor at Mississippi State University's College of Veterinary Medicine. Holding a PhD in Animal Physiology (MSU, 1994) and MS in Biological Sciences (MSU, 1990), he focuses on neurotoxicology, pesticide mechanisms, and endocannabinoid system interactions. His career spans 30+ years studying organophosphate effects on neurotransmitter systems across developmental stages. Key Research Areas: Organophosphate pesticide neurotoxicity Endocannabinoid system disruption Developmental neurochemical impacts Cross-species enzyme inhibition Recent Publications (2023-2021) reveal trends in nanochannel CBD delivery systems, chlorpyrifos-induced proteomic changes in amygdala, and multi-omics approaches to pesticide-immune interactions. Earlier works establish foundational knowledge on cholinesterase inhibition kinetics and age-dependent toxicity profiles. Notable Contributions: Elucidated mechanisms of endocannabinoid enzyme inhibition by pesticides, demonstrated neurochemical impacts of low-dose exposures, and developed comparative models across species (rodents, fish).

Jeffrey M. ChungView profile

Associate Professor

• Epilepsy
• Neural Signal Processing
• Neurosurgery
• +4 more

Jeffrey M. Chung, MD, FAAN is an Associate Professor of Neurology at Cedars-Sinai Medical Center. He serves as Director of both the Epilepsy Program and the Neurophysiology Laboratory since 2013. His clinical practice focuses on epilepsy and neurophysiology, with 26 years of experience in neurology and clinical neurophysiology. Northwestern University Medical School (1999) - MD Evanston Hospital (2000) - Internship UCLA (2003) - Residency UCLA (2005) - Fellowship Dr. Chung's research explores epilepsy mechanisms, neural signal processing , multi-modal probabilistic mapping for surgical outcomes, and device-oriented therapies . His recent publications focus on theta phase precession in memory , single-neuron correlates of seizures , and neuroimaging in post-stroke conditions . He leads clinical trials on novel anti-seizure agents and neuromodulation techniques. Circle of Friends – Grateful Patient Donation Honoree (Cedars-Sinai) Southern California Super Doctors (Los Angeles Magazine) Falks Medical Scholar (Arthritis Foundation) Golden Apple Teaching Award (Cedars-Sinai) Dr. Chung directs the Epilepsy Program and Neurophysiology Laboratory at Cedars-Sinai, while also mentoring through journal clubs and clinical teaching. He has received multiple industry grants from companies like Marinus Pharmaceuticals and Vertex Pharmaceuticals for trials on treatment-resistant epilepsy. His work bridges clinical care with neurophysiological research and advanced neural signal processing .

• Molecular Biology
• Biochemistry
• Neurodegenerative Diseases
• +10 more

Dr. Andrey L. Karamyshev is an Associate Professor at the School of Medicine, Texas Tech University Health Sciences Center, in the Department of Cell Biology & Biochemistry. His research focuses on molecular mechanisms of human diseases, particularly neurodegenerative disorders and cancer, through the lens of protein synthesis regulation and quality control. Academic Rank: Associate Professor Research Affiliation: Institute for One Health Innovation Research Interests include: Molecular mechanisms of translational regulation RNA and protein quality control Protein interactions in health and disease Signal Recognition Particle (SRP) dysfunction in neurodegenerative diseases Role of AGO2 in mRNA degradation Co-translational protein folding and targeting Recent Publications highlight his work on the RAPP pathway, SRP interactions in Leishmania, and protein misfolding in Parkinson’s and Alzheimer’s diseases. His studies integrate in vivo and in vitro methodologies, including photo-crosslinking and iPINCH techniques. Scientific Awards & Recognition : Featured in Trends in Biochemical Sciences (2014) Highlighted in Nature Reviews Genetics (2014) Recommended by Faculty of 1000 (F1000Prime) for multiple publications Top 5.0% viewed/downloaded article in Frontiers (2018) Dr. Karamyshev welcomes graduate students to his lab, emphasizing collaboration and innovative research in molecular biology and biomedical sciences. His lab is affiliated with the Institute for One Health Innovation, fostering interdisciplinary approaches to human disease treatment.

Bhanu JenaView profile

Professor

• Molecular and cellular physiology
• porosomes
• exocytosis
• +4 more

Bhanu Jena, Ph.D. (dr. hc. mult.) is the George E. Palade University Professor & Distinguished Professor at Wayne State University School of Medicine, Department of Physiology. He serves as Founder-Director of the Institute of NanoBioScience and maintains his laboratory at 5245 Scott Hall. As the only living University Professor and the second in Wayne State University's 160-year history, Dr. Jena holds one of the most prestigious academic appointments at the institution. Dr. Jena received his B.Sc. from BJB College in Orissa, India (1975), M.Sc. in Reproductive Endocrinology from Utkal University (1978), and Ph.D. in Reproductive Endocrinology from Iowa State University (1988). Following postdoctoral training at Iowa State and Yale Universities (1988-1994), he joined Yale University as an Assistant Professor before moving to Wayne State University in 2000 as a tenured full Professor. Dr. Jena's research centers on molecular and cellular physiology, with a groundbreaking focus on porosomes - the universal secretory machinery in cells that he discovered. His laboratory investigates how cells secrete, challenging traditional views of exocytosis. A second major research focus involves designing novel approaches, techniques, and instrumentation for biological problem-solving, including developing a force microscope capable of imaging intracellular structures at nanometer resolution in real-time. His recent publications reveal an evolving research trajectory spanning cellular secretion mechanisms, Alzheimer's disease therapeutic approaches, cystic fibrosis treatments, antiviral strategies against enveloped viruses, and advanced microscopy techniques. This multidisciplinary work bridges fundamental cell biology with clinical applications across neuroscience, respiratory diseases, and infectious disease. Elected Foreign Member of the Georgian National Academy of Science Fellow of the American Association for the Advancement of Science (AAAS) Swebelius Cancer Research Award Sir. Aaron Klug Award ASAS Basic Biological Science Award Ranbaxy Basic Research in Medical Sciences Award Elected Foreign Member of the Korea Academy of Science & Technology George E. Palade Gold Medal Six Honorary Doctorates With over 30 years of instructional experience, Dr. Jena teaches courses in cell biology, nanoscience/nanomedicine, physiology, endocrinology, and biochemistry. His lab receives primary funding from NIH and NSF grants. The Jena Lab continues to pioneer research on cellular nanomachines and their implications for human health, maintaining active collaborations across multiple disciplines while accepting new MS, PhD, and MD/PhD students into its research programs.

Tobias BonhoefferView profile

Professor

• Synaptic plasticity
• Learning and memory
• Activity-dependent development
• +4 more

Prof. Dr. Tobias Bonhoeffer serves as Director and Head of the Department of Synapses – Circuits – Plasticity at the Max Planck Institute for Biological Intelligence in Munich, Germany. His research focuses on synaptic plasticity, learning and memory, and the structural and functional dynamics of the visual system and hippocampus. Institution: Max Planck Institute for Biological Intelligence Department: Synapses – Circuits – Plasticity Academic Rank: Professor Research Interests encompass cellular and systems neurobiology, with specialized investigations into: Synaptic plasticity mechanisms Structural changes in dendritic spines Experience-dependent cortical circuit formation Memory relearning efficiency Functional mapping in visual cortex Neural adaptation in behaving animals Publications demonstrate expertise in neuroscience, particularly synaptic biology and neural circuit dynamics, with notable contributions to understanding cortical plasticity and hippocampal function. His lab has trained students like Sandra Reinert and Matthew McCann through the GSN program.

• Neurodegenerative Diseases
• Transmissible Spongiform Encephalopathies
• Viral Pathogenesis
• +4 more

Laura Manuelidis is Professor of Surgery (Neuropathology) and Section Chief of Neuropathology at Yale School of Medicine, where she directs the Manuelidis Laboratory focused on transmissible spongiform encephalopathies (TSEs). She holds secondary appointments in Virology and Surgery. Dr. Manuelidis earned her BA from Sarah Lawrence College (1963) and MD from Yale University (1967). Her research spans neurodegenerative diseases with emphasis on Creutzfeldt-Jakob Disease (CJD) and scrapie agents. Key contributions include: discovery of SPHINX DNA elements in mammalian brain cells; characterization of virus-like infectious particles; demonstration of blood-borne transmission routes; and challenge of the protein-only prion hypothesis through evidence of nucleic acid-dependent infectivity. Her current work explores prokaryotic DNA in neurodegeneration and innate immune responses to neuroinvasive agents. Analysis of her 15 most recent publications reveals consistent focus on: 1) Structural characterization of TSE infectious particles, 2) Role of nucleic acids in prion replication, 3) SPHINX DNA in synaptic function, 4) Novel decontamination methods, and 5) Neuronal responses to chronic infection. Her work integrates virology, molecular neurobiology, and proteomics. Honors include: Chromosoma Prize (1989) NIH Research Career Development Award (1974) Andrew W. Mellon Young Investigator Award (1974) Swibelius Award for Cancer Research (1970) She maintains continuous NIH R01 funding since 1970 and directs Yale's archival neuropathology repository (1951-1996). As FDA TSE advisory committee member, she contributes to blood safety policies. Her laboratory trains international researchers in neuropathological techniques and TSE biosafety protocols.

• Neuro-Ophthalmology
• Ophthalmology
• Cataract Surgery
• +3 more

Jacinthe Rouleau is a Clinical Associate Professor in the Department of Ophthalmology at the Faculty of Medicine, University of Montreal. She practices both general ophthalmology and neuro-ophthalmology at the CHUM (Centre hospitalier de l'Université de Montréal), where she serves as Chief of the Neuro-Ophthalmology Division. Her clinical focus includes cataract and glaucoma management, with expertise in cataract surgery since 2007. MD from Université Laval Ophthalmology residency at Université de Montréal Neuro-ophthalmology fellowship at the Department of Ophthalmology and Visual Science, University of Iowa Her research interests center on neuro-ophthalmic diagnostics, visual system function, and surgical innovation in cataract and glaucoma care. She actively contributes to clinical education through training programs and national/international conferences. At CHUM, Dr. Rouleau leads neuro-ophthalmology clinics and participates in ongoing research initiatives, including a funded project (2013-2014) evaluating the use of a "flicker meter" for optic nerve function testing.

• Neuro-oncology
• Minimally Invasive Surgery
• Awake Brain Surgery
• +6 more

Puneet Plaha is an Associate Professor and Consultant Neuro-Oncology Surgeon at the University of Oxford, based at the John Radcliffe Oxford University Hospitals since August 2012. He serves as Lead of the Oxford Neuro-oncology Multidisciplinary Team (MDT) and Lead for the Thames Valley Cancer Network for Brain Tumours, while chairing the Neuro-oncology section of the Society of British Neurological Surgeons. His educational qualifications include MBBS, MS, MD, FRCS, and FRCS (SN), reflecting extensive surgical and neurological training. Plaha's research centers on minimally invasive endoscopic techniques for brain tumor resection and advanced brain imaging to develop individualized treatments. He pioneered Oxford's Awake Surgery Brain Tumor Programme using intraoperative stimulation for supramaximal tumor resection. His work investigates neural network interactions with tumors, novel surgical modalities for safer procedures, immunotherapy applications, and clinical trials for brain cancer. Analysis of his 15 most recent publications (2023-2004) reveals dominant themes in glioblastoma treatment optimization, awake surgery refinement, and diffusion tractography applications. Key trends include immunotherapy integration (Ipi-Glio trial), pandemic impact on neuro-oncology care, and ultra-high-definition intraoperative imaging for low-grade glioma resection. As Chief Investigator for the UK NIHR-funded FUTURE-GB trial, Plaha leads multi-center glioblastoma research. His group also develops fast-track recovery protocols after minimally invasive tumor surgery and investigates neural network preservation during resection. No formal advisees are listed in available materials. He directs the Oxford Surgical Neuro-Oncology Research Group, which integrates clinical practice with translational research on tumor-immune interactions and surgical innovation, maintaining close collaboration with the Thames Valley Cancer Network for brain tumor management.

Jin Mo ChungView profile

Professor

• Chronic Pain
• Neuropathic Pain
• Synaptic Plasticity
• +7 more

Jin Mo Chung is a Professor and Chair at the University of Texas Medical Branch (UTMB), holding the Cecil H. and Ida M. Green Distinguished University Endowed Chair in Neuroscience and Cell Biology. His work focuses on chronic pain mechanisms, particularly neuropathic pain, where he developed the foundational 'spinal nerve ligation (SNL) Chung Model' for testing analgesics. With over 160 peer-reviewed publications and 23,000 citations, his research has been NIH-funded for 35 years, including multiple R01 and Program Project Grants. Education: BS in Physics, Sogang University PhD in Physiology, Loyola-Stritch School of Medicine Post-Doctoral in Neurophysiology, Loyola-Stritch Post-Doctoral in Somatosensory Neurophysiology, UTMB Chung's research spans synaptic plasticity in pain pathways, reactive oxygen species (ROS) in chronic pain, and treatment strategies for conditions like spinal cord injury, diabetic neuropathy, HIV infection, and chemotherapy-induced pain. He has pioneered animal models for pain research and explored interventions like spinal cord stimulation, antioxidant therapy, and electroacupuncture. The 15 most recent articles reflect a focus on pain neurobiology, ROS signaling, neuroinflammation, and neuromodulation techniques. Key subfields include FGF13 in diabetic neuropathy, Wnt5a signaling in HIV-related pain, opioid-induced hyperalgesia, circadian regulation of chemotherapy pain, and neuron-type-specific spinal cord stimulation. Scientific Contributions: Developed the 'Chung Model' of spinal nerve ligation Over 160 peer-reviewed publications NIH R01 and Program Project Grants (35 years) Co-editor of Encyclopedia of Pain Chung has mentored 30 postdoctoral fellows and 22 visiting scientists. He co-founded the Association of Korean Neuroscientists and led the Gulf Coast Consortium and Texas Pain Research Consortium. His work connects basic science to clinical applications, with global impacts on analgesic drug development.

Saumen SarkarView profile

Professor

• Type I Interferon Signaling
• Antiviral Innate Immunity
• IFN-Stimulated Genes
• +4 more

Dr. Saumen Sarkar is a Professor in the Department of Microbiology and Immunology at the University of Maryland School of Medicine, with an additional appointment in the Program in Oncology. His research focuses on innate immune signaling during viral infections and cancer, particularly mechanisms of type I interferon (IFN) induction and modulation by host components like the OAS family genes. He has authored over 77 publications spanning virology, immunology, and molecular biology. Education: PhD in Molecular Biophysics (Indian Institute of Science), MSc in Biophysics (University of Calcutta), BSc (University of Calcutta) His work explores the dual antiviral and antibacterial functions of OAS1, interactions between RIG-I and OASL, and the role of interferon regulatory factors in tumor progression and immunotherapy. Key contributions include elucidating how OASL enhances RIG-I signaling and identifying novel immune-modulating roles for TLR3 tyrosine residues. Recent publications (2024) highlight OAS1's mechanisms in translational shutdown during viral infection and its newly discovered antibacterial functions via IRF1. Earlier work (2019-2010) addresses DNA virus immune evasion, MAVS regulation, and translational research in head/neck cancers. Dr. Sarkar's research integrates structural biology (e.g., 2003 OAS crystal structure) and systems approaches (2024 cell-type-specific networks) to understand host-pathogen interactions and tumor immunity.

• Neurotoxicology
• Developmental Neuroscience
• Environmental Toxicology
• +3 more

Per Eriksson is a Professor at the Department of Organismal Biology; Physiology and Environmental Toxicology at Uppsala University. His research focuses on the neurotoxic effects of environmental chemicals and radiation on brain development, with particular emphasis on how these exposures during critical neonatal periods lead to long-term neurobehavioral consequences. His research interests span several interconnected domains: Developmental neurotoxicology of environmental chemicals Neurobehavioral effects of flame retardants (particularly PBDEs) Interactions between multiple toxicants during brain development Long-term cognitive and behavioral outcomes of early-life exposures Mechanisms of neurotoxicity at cellular and molecular levels Professor Eriksson's publication record demonstrates a consistent research trajectory examining how combinations of chemicals (such as perfluorinated compounds with brominated flame retardants, or radiation with pharmaceuticals) produce synergistic effects that exacerbate neurodevelopmental problems. His work frequently employs mouse models to investigate dose-response relationships, critical exposure windows, and sex-specific vulnerabilities. His laboratory has trained numerous researchers who have become established scientists in toxicology and neuroscience. Professor Eriksson's work has significantly contributed to understanding how environmental factors can disrupt normal brain development and increase susceptibility to neurological disorders later in life.

Svetlana N. RadyukView profile

Research Professor

• Redox Regulation
• Innate Immunity
• Aging Mechanisms
• +5 more

Svetlana N. Radyuk serves as a Research Associate Professor in the Department of Biological Sciences within Dedman College of Humanities and Sciences at Southern Methodist University. Her laboratory (DLSB 317) focuses on the molecular mechanisms linking redox regulation, innate immunity, and aging processes using Drosophila melanogaster as a primary model system. Her research centers on redox regulation of innate immunity during aging , specifically investigating how peroxiredoxins modulate immune responses and longevity. Key areas include: Role of reactive oxygen/nitrogen species (ROS/RNS) as dual-function molecules causing tissue damage while serving as immune signaling messengers Conserved functions of peroxiredoxins across biological kingdoms in regulating redox homeostasis Age-related immune decline including reduced pathogen resistance, impaired T/B cell function, and chronic inflammation Interactions between circadian clocks, redox balance, and aging processes Analysis of her 15 most recent publications reveals a consistent focus on peroxiredoxin-mediated redox signaling in Drosophila models, with recent expansion into hydrogen gas therapeutics for oxidative stress-related conditions. Her work demonstrates how precise ROS/RNS regulation balances immune protection against tissue damage, with significant implications for age-related diseases. Dr. Radyuk currently holds two major NIH/NIA-funded research grants: R01 AG032342 (Principal Investigator): Peroxiredoxins, immune signaling and aging (2011-2016) R01 AG045830 (Co-PI): Circadian clocks and aging (2013-2018) Her teaching portfolio includes advanced courses in Immunobiology (BIOL 4319), Molecular Genetics Laboratory (BIOL 3222), and graduate-level research/thesis supervision (BIOL 6270, 8398). Her laboratory employs comprehensive molecular biology and genetics techniques to investigate redox-immunity interactions, with particular emphasis on developing interventions that maintain optimal immune function during aging.

Nikolaos LourosView profile

Assistant Professor

• Protein Misfolding and Aggregation
• Amyloid Formation
• Neurodegenerative Diseases
• +7 more

Nikolaos Louros is an Assistant Professor at UT Southwestern Medical Center, with dual affiliations to the Center for Alzheimer's and Neurodegenerative Diseases (CAND) and the Department of Biophysics. He leads the Louros Lab, which focuses on protein misfolding, aggregation, and amyloid formation in neurodegenerative diseases. His research integrates AI-driven protein engineering with biophysical, structural, and cellular methods to develop novel therapeutics. B.S. in Biology, National and Kapodistrian University of Athens (2011) MSc in Bioinformatics (2014) Ph.D. in Cell Biology and Biophysics, NKUA (2016) Postdoctoral training at VIB-KU Leuven Center for Brain & Disease Research, Belgium Dr. Louros' research centers on the molecular mechanisms of protein aggregation, particularly in Alzheimer’s and Parkinson’s diseases. His lab investigates amyloid polymorphism, heterotypic interactions, and the role of post-translational modifications like glycosylation in proteostasis. Using computational tools and experimental validation, his team aims to identify aggregation modifiers and design novel inhibitors. His recent publications reveal a strong focus on amyloid structure, calcium dysregulation, and therapeutic targeting. Key themes include tau and Aβ polymorphism, co-aggregation with proteins like Medin, and the use of AI to map aggregation-prone sequences. His work frequently appears in top-tier journals such as Nature , Science , Cell , and Nature Reviews Molecular Cell Biology . Pharmacological modulation of septins in Alzheimer’s models Medin-Aβ co-aggregation in vascular amyloid AI-guided mapping of amyloid sequence space Structural basis of tau polymorphism Therapeutic targeting of pathogenic tau seeds Dr. Louros has not been listed with formal scientific awards in the provided text, but his publication record and leadership role indicate significant recognition. He is actively mentoring students and postdocs, as his lab is recruiting for Ph.D. candidates and research associates. The Louros Lab operates within the Peter O'Donnell Jr. Brain Institute, fostering interdisciplinary collaboration in neuroscience and biophysics. The lab employs a hybrid, inquiry-driven approach, combining deep learning, protein engineering, and high-throughput experimentation. It maintains strong collaborative ties with leading institutions and researchers in the field of neurodegeneration and protein science.

• Cardiac Electrophysiology
• Cardiac Arrhythmias
• Lysosomal Calcium Signaling
• +5 more

Associate Professor Rebecca Burton is a cardiac electrophysiologist in the Department of Pharmacology at the University of Oxford's Medical Sciences Division. Since completing her DPhil in 2006, she has led research on cardiac arrhythmias with focus on lysosomal calcium signaling and hydroxychloroquine's effects on heart rhythm. Her group of approximately 10 researchers employs novel imaging methods and traditional pharmacology techniques to study cardiac function. Her research interests center on cardiac arrhythmia mechanisms, particularly the role of lysosomal calcium stores in atrial fibrillation. She investigates cAMP-Ca 2+ cross talk in atrial nanodomains, IP3 receptor signaling , and acidic organelle function in cardiomyocytes. Her work bridges basic science with translational applications through collaborations with clinicians across disciplines. Her 15 most recent publications (2022-2025) demonstrate consistent focus on lysosomal calcium signaling in cardiac rhythm regulation, with particular emphasis on atrial-specific mechanisms. Key themes include compartmentalized cAMP signaling, NAADP-mediated calcium release, and the role of endolysosomal networks in atrial fibrillation pathophysiology. Scientific recognition includes: Winston Churchill Medal for contributions to Science and Technology (2015-2016) Sir Henry Dale Fellowship supporting her ambitious interdisciplinary research Beyond research, Burton serves in teaching roles including examination setting and marking, provides pastoral care at her college, and actively engages in public outreach through events like the Science Museum Lates. She has advocated for improved career pathways for early-career researchers and greater equality of opportunity in academia. Her laboratory specializes in advanced cardiac optical mapping, lysosomal calcium imaging, and multi-disciplinary approaches to studying the neuro-cardiac axis, with particular focus on how sympathetic neuronal activity affects cardiac conduction and arrhythmia susceptibility.